Safety and efficacy of combination therapy of interferon ‐α2 and ruxolitinib in polycythemia vera and myelofibrosis

Cancer Medicine, EarlyView.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Source Type: research